Invention Grant
US09096593B2 Compounds and methods for kinase modulation, and indications therefor
有权
用于激酶调节的化合物和方法及其适应症
- Patent Title: Compounds and methods for kinase modulation, and indications therefor
- Patent Title (中): 用于激酶调节的化合物和方法及其适应症
-
Application No.: US14033291Application Date: 2013-09-20
-
Publication No.: US09096593B2Publication Date: 2015-08-04
- Inventor: Jiazhong Zhang , Prabha N. Ibrahim , Ryan Bremer , Wayne Spevak , Hanna Cho
- Applicant: Plexxikon Inc.
- Applicant Address: US CA Berkeley
- Assignee: Plexxikon Inc.
- Current Assignee: Plexxikon Inc.
- Current Assignee Address: US CA Berkeley
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/4427 ; C07D471/04 ; A61K31/437 ; A61K31/506 ; C07D401/04

Abstract:
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, or forms thereof are active on Fms protein kinase, or on Fms and Kit protein kinase, or on Fms and Flt-3 protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinase, Kit protein kinase, or Flt-3 protein kinase including rheumatoid arthritis, osteoarthritis, multiple sclerosis, Alzheimer's disease, Parkinson's disease, glomerulonephritis, interstitial nephritis, Lupus nephritis, tubular necrosis, diabetic nephropathy, renal hypertrophy, acute myeloid leukemia, melanoma, multiple myeloma, metastatic breast cancer, prostate cancer, pancreatic cancer, neurofibromatosis, brain metastases, and gastrointestinal stromal tumors.
Public/Granted literature
- US20140045840A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Public/Granted day:2014-02-13
Information query